February 6, 2018 M&A, Partnerships Microscopy

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems

QIAGEN’s QuantiFERON-TB customers to gain access to fully automated workflow solution DiaSorin to add novel content to already broad LIAISON menu, over 7,000 systems installed QIAGEN announces milestone of over 40 million QuantiFERON-TB tests since launch January 8, 2018 – Saluggia, Italy; Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Stock Exchange:... Read more

February 5, 2018 Lab Top-10 Liq. Handling & Robotics M&A, Partnerships

Abcam and Molecular Devices announce strategic collaboration

First CatchPoint®SimpleStep®ELISA kits launching at SLAS 2018, Feb 3-7, San Diego, USA Cambridge, UK, San Jose, CA, USA, February 5, 2018: Abcam, a global innovator in life science reagents and tools, and Molecular Devices, LLC, a leading provider of high-performance bioanalytical measurement solutions for the life science industry, today announced a strategic collaboration to develop... Read more

February 5, 2018 M&A, Partnerships Mass Spectrometry

SCIEX Announces Co-Marketing Agreement with IROA Technologies LLC to Improve Metabolite Identification & Quantitation in Complex Samples for Untargeted Metabolomics

SCIEX and IROA Technologies LLC to Offer Complete Solution for Next Generation Metabolomics, to Allow Unambiguous Identification and Quantitation of Metabolites in a sample February 05, 2018 Framingham, MA — SCIEX, a global leader in life science analytical technologies, today announced a co-marketing agreement with IROA Technologies LLC, a reagents and kits company specializing in metabolomics analyses. This... Read more

February 5, 2018 Licensing, IP, and Legal Liq. Handling & Robotics M&A, Partnerships

QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing

Germantown, Maryland, and Hilden, Germany, January 31, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire STAT-Dx, a privately-held company developing the next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR... Read more

February 1, 2018 M&A, Partnerships

AMETEK Completes Two Acquisitions

BERWYN, Pa., Feb. 1, 2018 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) today announced that it has completed two acquisitions; FMH Aerospace, a leading provider of complex, highly-engineered solutions for the aerospace, defense and space industries and Arizona Instrument, a provider of differentiated, high-precision moisture and gas measurement instruments. Combined, approximately $273 million was deployed on these... Read more

January 31, 2018 M&A, Partnerships

Harvard Bioscience Completes Acquisition of Data Sciences International

HOLLISTON, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that the Company has completed the previously announced acquisition of Data Sciences International, Inc. (“DSI”). The aggregate consideration payable by the Company in... Read more

January 31, 2018 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing

New system launch planned for second half of 2018 with two CE-IVD molecular diagnostics, U.S. launch planned for 2019 and broad pipeline in development Germantown, Maryland, and Hilden, Germany, January 31, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today it has entered into an agreement to acquire STAT-Dx, a privately-held company developing... Read more

January 31, 2018 M&A, Partnerships PR/Corporate

QIAGEN reports results for fourth quarter and full-year 2017, announces STAT-Dx acquisition and new $200 million share repurchase

Solid Q4 results as QIAGEN achieves full-year 2017 targets: Q4 2017: Net sales $396.9 million ( 8% actual, 5% CER); adjusted net sales rise 6% CER excluding portfolio changes vs. 5-6% CER guidance  Q4 2017: EPS -$0.18 including impact of predominantly non-cash U.S. tax reform charge; adjusted EPS $0.43 ($0.43 CER) vs. ~$0.41-42 CER guidance... Read more

January 30, 2018 Lab Top-10 M&A, Partnerships

Agilent Partners with Science Exchange

Agilent Partners with Science Exchange Partnership Promotes Secure Research Services Powered by Agilent Solutions SANTA CLARA, Calif., Jan. 30, 2018 Agilent Technologies Inc. (NYSE: A) today announced a partnership withScience Exchange, the world’s leading enterprise platform for outsourced research and development services. The partnership will promote access to Agilent-enabled services to the research community worldwide.... Read more

January 29, 2018 Acad, Gov/Utilities Lab Top-10 M&A, Partnerships

Agilent Announces Scientific Collaboration with the University of Southern California

Agilent Announces Scientific Collaboration with the University of Southern California Collaboration aims to facilitate transformational biomedical science and engineering research SANTA CLARA, Calif., Jan. 29, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it has formed a strategic scientific collaboration with the University of Southern California (USC) Michelson Center for Convergent Bioscience to create... Read more